DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study by Jackson, Philippa et al.
Citation:  Jackson,  Philippa,  Reay,  Jonathon,  Scholey,  Andrew  and  Kennedy,  David  
(2012) DHA-rich  oil  modulates the cerebral  haemodynamic response to cognitive  tasks  
in  healthy  young adults: a near IR spectroscopy pilot  study. British  Journal  of Nutrit ion,  
107 (8). pp. 1093-1098. ISSN 1475-2662
Published by: Cambridge University  Press
URL: http://dx.doi.org/10.1017/S0007114511004041
This  version  was  downloaded  from  Northumbria  Research  Link:  
http://nrl.northumbria.ac.uk/4238/
Northumbria  University  has  developed Northumbria  Research  Link  (NRL)  to  enable 
users to access the University’s research output.  Copyright  © and moral  rights  for  items 
on NRL  are retained by the individual  author(s) and/or other  copyright  owners.  Single  
copies of full  items can be reproduced, displayed or performed, and given to third  parties  
in  any  format  or  medium  for  personal  research or  study,  educational,  or  not-for-profit  
purposes without  prior  permission  or  charge,  provided  the  authors,  tit le  and  full  
bibliographic  details  are  given,  as  well  as  a  hyperlink  and/or  URL  to  the  original  
metadata  page. The content  must  not  be changed in  any way.  Full  items must  not  be 
sold commercially  in  any format  or medium  without  formal  permission of the copyright  
holder.  The full  policy is available online: http://nrl.northumbria.ac.uk/policies.html
This document  may differ  from the final,  published version of the research and has been 
made available online in  accordance with  publisher  policies. To read and/or cite from the  
published  version  of the  research,  please visit  the  publisher’s  website  (a subscription  
may be required.)
Short Communication
DHA-rich oil modulates the cerebral haemodynamic response to cognitive
tasks in healthy young adults: a near IR spectroscopy pilot study
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Abstract
The impact of dietary n-3 PUFA on behavioural outcomes has been widely researched; however, very little attention has been given to their
impact on brain functioning in physiological terms. A total of twenty-two healthy adults took part in this double-blind, placebo-controlled
study, wherein the cerebral haemodynamic effects of 12 weeks of daily dietary supplementation with either 1 g DHA-rich or 1 g EPA-rich
fish oil (FO) or placebo (1 g olive oil) were assessed. Relative changes in the concentration of oxygenated Hb (oxy-Hb) and deoxygenated
Hb were assessed in the prefrontal cortex using near IR spectroscopy (NIRS) during the performance of four computerised cognitive tasks.
Supplementation with DHA-rich FO, in comparison with placebo, resulted in a significant increase in the concentrations of oxy-Hb and
total levels of Hb, indicative of increased cerebral blood flow (CBF), during the cognitive tasks. In comparison, no effect on CBF was
observed following supplementation with EPA-rich FO, where concentration changes in the chromophores followed the same pattern
as placebo. These encouraging pilot data warrant further application of NIRS in this area.
Key words: DHA: EPA: Near IR spectroscopy
The impact of dietary n-3 PUFA on human health has been
increasingly examined in recent years. This unique class of
fatty acids comprises the essential parent precursor fatty acid
a-linolenic acid and principal metabolites include DHA and
EPA. a-Linolenic acid cannot be manufactured de novo and
must be supplied via dietary sources and is primarily found
in seed oils such as flax and rapeseed. The more biologically
relevant longer-chain fatty acids DHA and EPA can be syn-
thesised from a-linolenic acid; however, this process is limited
in humans(1). A better dietary source of these fatty acids is
therefore preformed DHA and EPA, which are abundant in
oily fish. DHA is heavily concentrated in the mammalian
brain and comprises 10–20 % of the fatty acids found in this
organ(2). DHA maintains the structural integrity of neuronal
cell membranes and has an impact on numerous signalling
pathways and neurotransmitter systems(3,4). EPA, although
not a major component of the brain, could potentially influence
brain function via the action of its many eicosanoid derivatives;
regulators of key immune, endocrine and cardiovascular
functions(5,6). A large body of research now exists describing
the effects of dietary n-3 PUFA on behaviour; however, very
little attention has been given to evaluating their impact on
brain function in physiological terms, with only a limited
number of preclinical and clinical trials to date addressing
this issue(7–9).
A viable approach to exploring the effects of dietary n-3
PUFA on brain function is by measuring cerebral haemo-
dynamics using functional near IR spectroscopy (NIRS), a
well-validated and non-invasive optical imaging technique.
NIRS is based on the intrinsic optical absorption properties
of oxygenated Hb (oxy-Hb) and deoxygenated Hb (deoxy-
Hb), and can be used as a measure of activation of neural
tissue or simply as a measure of local cerebral blood flow
(CBF) in the top layers of the cortex. Total-Hb (the sum of
oxy- and deoxy-Hb) is closely related to cerebral blood
volume, from which changes in regional CBF (rCBF) can be
inferred(10). Total-Hb also correlates well with rCBF changes
as measured using the labelled water technique(11), although
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studies using rat brain models suggest that oxy-Hb is a better
measure of rCBF than total-Hb(12). NIRS has been successfully
used to image activation in the frontal cortex (Fallgatter &
Strik(13,14)) and other areas of the brain including the
temporal, visual and parietal cortices (Schecklmann et al.(15);
Jasdzewski et al.(16)). Only a small number of trials published
to date have utilised NIRS in pharmacological interventions
(Kanamaru et al.(17); Bonoczk et al.(18)); data from our
own laboratory have recently demonstrated increased rCBF
following administration of a vasodilator (resveratrol(19)) and
decreased rCBF following a vasoconstrictor (caffeine(20)),
supporting the application of NIRS in this area.
To date, research has primarly focused on the effects of DHA
on brain function, given the high proportion of this fatty acid
found in this organ. However, it is also possible that EPA
could also have an impact on the cerebrovascular parameters,
given that this fatty acid is readily incorporated into endo-
thelial cell membranes elsewhere in the cardiovascular
system(21) and has been shown to modulate local CBF in
aged, stroke-prone rats(22). Therefore, the objective of the pre-
sent pilot trial was to investigate any treatment-related effects
of 12 weeks of supplementation with DHA- and EPA-rich fish
oil (FO) in healthy volunteers on the cerebral haemodynamic
response to cognitive tasks in the prefrontal cortex.
Experimental methods
Participants
A total of twenty-two healthy adults took part in the study
(nine male; mean age 21·96 years; mean BMI 23·04 kg/m2).
All participants declared that they were in good health, non-
smokers, free from prescription medication and social drugs,
free from n-3 supplements and native English speakers. The
participants also confirmed that they did not consume more
than one portion of oily fish per week. At the time of testing,
the participants were enrolled in a larger intervention trial
assessing the cognitive and mood effects of 12 weeks of diet-
ary supplementation with FO and were invited to take part in
an extra testing session once they had completed their
12-week cognitive assessment(23).
The present study was conducted according to the
guidelines laid down in the Declaration of Helsinki, and
all procedures involving participants were approved by
the Northumbria University School of Life Sciences Ethics
Committee. Written informed consent was obtained from all
the participants.
Treatments
Before the start of the behavioural intervention study, a
restricted randomisation list matching treatments to participant
code numbers was generated by the computer. The partici-
pants were therefore randomly allocated to one of three
treatment groups, DHA-rich FO, EPA-rich FO and placebo.
The 1 g daily dose was provided by 2 £ 500 mg capsules.
Each active 500 mg capsule contained 497·5 mg of deodorised
FO þ 2·5 mg mixed tocopherols. The total daily dose of n-3
PUFA provided by 2 £ 500 mg capsules for the DHA-rich FO
was 450 mg DHA þ 90 mg EPA (DHA 5:1 EPA), and for the
EPA-rich FO, this was 300 mg EPA þ 200 mg DHA (EPA 3:2
DHA). The total daily dose for the placebo treatment was
1 g olive oil, again provided by 2 £ 500 mg capsules. Treat-
ment oils were purchased from EPAX AS (Aalesund,
Norway) and encapsulated by Cardinal Health UK. All cap-
sules used a brown bovine gelatine casing, and all treatments
were packaged, labelled and randomised on site by a disinter-
ested third party.
Near IR spectroscopy
The guiding principle of NIRS is that the chromophores
oxy-Hb and deoxy-Hb absorb light at different wavelengths.
Therefore, by measuring the amount of light absorbance at
a specific wavelength, the concentrations of oxy-Hb and
deoxy-Hb can be calculated(13). The third outcome produced
by NIRS measurements – total Hb – is simply the sum of oxy-
Hb and deoxy-Hb. In the present study, relative changes in the
absorption of near IR light were measured using a 12-channel
continuous-wave Oxymon system (Artinis Medical Systems
B.V., Zetten, The Netherlands), described previously by
Kennedy et al.(19). In this system, two nominal wavelengths
of light (approximately 765 and 855 nm) are introduced
through the skull via a laser emitter and measured, following
transit through the upper surface of the cortex, by an optode
placed at a preset distance from the light source (40 mm in this
case). At this distance, the NIR signal is sensitive to haemo-
dynamic changes within the top 2–3 mm of the cortex(24).
Given the experimental aims a simple two-channel configur-
ation was used in this instance, with data collected from the
areas of the frontal cortex corresponding to the International
10-20 system Fp1 and Fp2 EEG positions. NIRS data were
time stamped by the researcher at the start and end of each
task so that only NIRS data collected during the tasks
were analysed. Recorded data were stored as a. TXT file and
analysed using SPSS 16.0 (SPSS, Inc., Chicago, IL, USA).
Cognitive tasks
A total of four tasks were administered using the Compu-
terised Mental Performance Assessment System, a software
platform for the presentation of classic and bespoke compu-
terised cognitive tasks. For accurate measurements, the NIRS
optodes are required to make good contact with skin; there-
fore, the measures of haemodynamic response in the frontal
cortex are most effective, given that the forehead is naturally
free from hair. To this end, the tasks were selected on the
basis that execution of the same or a similar task has pre-
viously been shown to activate the prefrontal cortex in brain
imaging studies (Stroop task(25); peg-and-ball task, 3-back
task(26); Wisconsin card sort task(27)).
The tasks were presented via a laptop computer in the same
order as listed below. Progress through the battery of tasks
was controlled by the participant, with brief instructions
given onscreen before the start of each task. A 60 s rest
period between each task was incorporated into the battery
P. A. Jackson et al.1094
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commencing as soon as the last response of the previous task
had been made and ended with the presentation of the onsc-
reen instructions for the next task. The cognitive data were not
analysed.
The tasks were completed in the following order: Stroop
task (5 min); peg-and-ball task (2·5 min); 3-back task (4 min);
Wisconsin card sort task (3 min). Full descriptions of the
Stroop, peg-and-ball and Wisconsin card sort tasks can be
found in Kennedy et al.(28). For the 3-back task, a continuous
string of letters (upper and lower case; inter-stimulus interval
of 2·5 s) was presented: seventy-eight letters in total with
thirty-six target pairs. For each stimulus, the participants
were instructed to indicate using a yes/no key press whether
this was the same letter that appeared three letters previously.
Procedure
As part of a larger randomised, intervention trial investigating
the effects of two types of FO on cognitive function and
mood, the participants had been taking a daily 1 g supplement
of either EPA-rich FO, DHA-rich FO or olive oil placebo for 12
weeks. Towards the end of the 12-week period, the partici-
pants were invited via email to take part in an extra cognitive
testing session with concurrent NIRS data collection. In all
cases, this assessment either took place on the same day as
the final behavioural testing session or the following day
(average time on treatment 88·59 (SEM 3·9) d). Therefore, the
final treatment dose was consumed 1 or 2 d before the NIRS
testing session. Testing took place in the afternoon, and the
participants were instructed to refrain from consuming food
and drink except water for a minimum of 2 h before testing.
On arrival, the participants were seated in front of the
laptop computer used for presenting the cognitive tasks.
They were fitted with the NIRS headband and were instructed
to sit quietly with their eyes closed until they were given
further instruction by the researcher to start the cognitive
tasks. Recording of NIRS data was initiated following 30 s of
eyes-closed relaxation, and the participant was instructed to
begin the tasks after a further 2 min of eyes-closed relaxation.
This 2 min period was utilised as the NIRS resting baseline
measurement. The participants completed each task with
NIRS data collected throughout.
Treatment compliance
The results for compliance as measured by capsule count
were similar in all three treatment conditions (89 % DHA-rich
FO, 87 % EPA-rich FO and 88 % placebo). As part of the beha-
vioural intervention trial, the participants were required to
give two venous blood samples, once before supplementation
and again at the week 12 time point. The samples were
collected and analysed as described by Jackson et al.(23); avail-
able data for the participants who completed the NIRS assess-
ment are presented in Table 1.
Statistical methods
Changes in concentration (compared with resting baseline) of
oxy-Hb and deoxy-Hb were averaged across the two channels
(hemispheres) before analysis. Data collected during each task
were averaged over the 2·5–5 min of task performance. The
resultant data therefore represent the change in the concen-
tration of each of the chromophores, plus their sum–total
Hb–during each complete task period with respect to the
pre-testing 2 min baseline measurement. As the duration of
each task was substantially longer than the potential physio-
logical oscillations that can cause a drift in shorter periods of
the NIRS recording (e.g. heartbeat and respiration(29)), no
adjustment was made to the data for this phenomenon.
The primary analysis of the averaged NIRS data was con-
ducted by one-way ANOVA for each task with a priori
planned comparisons of the data from each task being made
between placebo and each treatment group (DHA-rich FO,
EPA-rich FO) using t tests calculated with the mean squares
error of the overall ANOVA(30). To protect against an increased
type I error rate, only those planned comparisons associated
with a significant main effect of treatment on the ANOVA are
reported.
Results
Oxygenated Hb
There was a significant main effect of treatment on oxy-Hb,
while participants completed the Stroop task (F(2,19) ¼ 3·72,
P¼0·043). Reference to the planned comparisons showed a
significant increase in the concentration of oxy-Hb following
Table 1. Serum concentrations of DHA and EPA (% total fatty acid methyl esters) of samples col-
lected at baseline and week 12
(Mean values with their standard errors)
Baseline Week 12
n Mean SEM n Mean SEM t * P *
DHA† Placebo 6 1·07 0·28 6 1·33 0·26 0·48 0·655
DHA-rich FO 6 0·87 0·13 6 1·71 0·32 2·93 0·033
EPA-rich FO 6 0·72 0·14 4 1·09 0·33 5·18 0·014
EPA† Placebo 5 0·95 0·31 5 0·97 0·12 0·26 0·806
DHA-rich FO 6 0·71 0·26 6 1·31 0·13 2·12 0·088
EPA-rich FO 7 0·95 0·20 4 1·13 0·27 0·70 0·559
FO, fish oil.
* t and P values are obtained from paired sample t tests (baseline and week 12).
† Serum fatty acid analytical methods are described in full in Jackson et al.(23).
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the DHA-rich FO during this task compared with placebo
(P¼0·013). The trends for an effect of treatment were
observed for the peg-and-ball and the 3-back tasks
(F(2,19) ¼ 3·35, P¼0·057; F(2,19) ¼ 2·69, P¼0·093, respect-
ively) (Fig. 1).
Deoxygenated Hb
The ANOVA revealed no treatment-related effects on the con-
centrations of deoxy-Hb during any of the cognitive tasks.
Total Hb
The ANOVA showed that there was a significant effect of
treatment on total-Hb during the Stroop, peg-and-ball and
3-back tasks (F(2,19) ¼ 4·93, P¼0·019; F(2,19) ¼ 4·21,
P¼0·031; F(2,19) ¼ 3·57, P¼0·048, respectively). Reference
to the planned comparisons showed a significant increase in
total-Hb in the DHA-rich FO treatment condition compared
with placebo during all three of these tasks (Stroop (P,0·006);
peg-and-ball task (P,0·009); 3-back task (P,0·016) (Fig. 1).
Planned comparisons did not reveal any significant
difference in task-related concentration changes in any of
the chromophores in the EPA-rich FO treatment condition,
in comparison with placebo. Averaged data for each treatment
group during the task periods are shown in Table 2.
Discussion
The present results reveal that supplementation with DHA-rich
FO was associated with a significant increase in rCBF in the
prefrontal cortex in response to cognitive task performance,
in comparison with placebo, as indexed by changes in the
concentration of oxy-Hb and total-Hb. Given that a similar
pattern of results was not observed in participants who were
administered EPA-rich FO, which also contained DHA, it
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Fig. 1. Concentration changes in oxygenated (Doxy-Hb) and total Hb (DTotal-Hb) by treatment group (placebo ( ), DHA-rich fish oil (FO; ), EPA-rich FO ( ))
during the cognitive task periods. Data are averaged across both hemispheres (left/right). Significance is compared with placebo (t tests using the mean squares
error from the omnibus ANOVA). Values were significantly different: *P,0·05; **P,0·01; t, 0·05 , P,1. Stroop, Stroop task; P-B, peg-and-ball task; 3-back, 3-
back task; WCST, Wisconsin card sort task.
Table 2. Average change in concentration (mmol/l, calculated from a 2 min pre-testing baseline) of oxygenated Hb (oxy-Hb), deoxyge-
nated Hb (deoxy-Hb) and total Hb for each of the treatment groups (placebo, DHA-rich fish oil (FO), EPA-rich FO) during the cognitive
tasks
(Mean values with their standard errors)
Placebo (n 7) DHA-rich FO (n 7) EPA-rich FO (n 8)
Mean SEM Mean SEM Mean SEM F * P *
Stroop Oxy-Hb 21·41 0·43 0·51 0·59 20·44 0·43 3·72 0·043
Deoxy-Hb 20·21 0·16 20·22 0·15 0·02 0·07 1·22 0·317
Total-Hb 21·62 0·33 0·28 0·53 20·42 0·39 4·93 0·019
Peg-and-ball Oxy-Hb 21·65 0·78 1·14 0·91 21·13 0·71 3·34 0·057
Deoxy-Hb 20·55 0·24 20·40 0·35 0·07 0·17 1·65 0·219
Total-Hb 22·20 0·66 0·75 0·79 21·06 0·67 4·21 0·031
3-back Oxy-Hb 21·26 0·93 1·80 1·05 20·44 0·86 2·69 0·093
Deoxy-Hb 20·63 0·28 20·33 0·29 20·09 0·16 1·25 0·310
Total-Hb 21·89 0·73 1·47 1·04 20·53 0·82 3·57 0·048
WCST Oxy-Hb 20·84 1·16 2·23 1·04 20·49 0·99 2·42 0·116
Deoxy-Hb 20·71 0·29 20·40 0·39 20·07 0·15 1·30 0·296
Total-Hb 21·55 0·98 1·82 0·99 20·56 0·94 3·06 0·070
* F and P values are obtained from the primary ANOVA.
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would appear that the rCBF response to the tasks is only
modulated following supplementation with DHA at a dose
higher than 200 mg/d.
The pattern of concentration changes in oxy-Hb and total-
Hb in the EPA-rich FO group did not differ from placebo,
suggesting that the addition of dietary EPA at a dose of
300 mg/d for 12 weeks has no impact on cerebral haemo-
dynamic response to cognitive tasks in this population.
However, referring to the limited serum fatty acid data indi-
cates that serum concentrations of EPA in this treatment
group did not significantly increase following the 12-week
intervention, despite a similarly high level of compliance
with the treatment regimen being followed as in those
administered the DHA-rich FO. Therefore, the impact of EPA
supplementation on cerebrovascular response to cognitive
tasks may require further exploration, and future investi-
gations at doses higher than the present study would be
advised. That being said, Sublette et al.(31) found significant
correlations between cerebral metabolic rates of glucose
(tempoparietal and frontal cortices, anterior cingulate) and
peripheral concentrations of DHA and arachidonic acid, but
not of EPA, suggesting instead that EPA may simply not have
an impact on cortical activity, possibly due to, as these authors
also predict, the very small amount of EPA found in the brain
(approximately 1 % total fatty acids(2)).
The pattern of increased oxy-Hb and total-Hb in the DHA-
rich FO treatment group, compared with placebo, is in agree-
ment with recent data published by McNamara et al.(9). Using
fMRI, these authors revealed that compared with placebo,
DHA supplementation for 8 weeks resulted in increased acti-
vation of the dorsolateral prefrontal cortex during a sustained
attention task in thirty-three schoolchildren (male, 8–10
years). It is worth noting that the NIRS parameters generated
in the present study have been shown to closely correspond
to the fMRI blood oxygen level-dependent signal(32),
suggesting consistency of findings across these two para-
digms. Interestingly, the authors also report null effects of
the treatment on cognitive performance measures, despite
the observed increase in cortical activity. Although the
sample size in the present study was too small to permit an
analysis of the behavioural data, performance measures ana-
lysed from the larger intervention trial described by Jackson
et al.(23) from which the current sample was drawn revealed
no effect of either active treatment (DHA-rich FO and EPA-
rich FO) on cognitive performance overall. The results from
both studies suggest that the administration of DHA may
improve the overall function and health of the brain, in
terms of increased CBF, but that this is simply not manifested
in a strong pattern of observable behavioural measures in
young, healthy populations. A possibility is that improved
function in terms of both haemodynamic response and beha-
viour may only be apparent in groups characterised by either
natural or disease-related cerebrovascular insufficiency. Of
course, it may also be the case that the length of the interven-
tion in both our own study and the study described by McNa-
mara et al.(9) was too short for any potential behavioural
effects to be observed. However, longer intervention trials,
in children at least, have reported similar null findings
(Kirby et al.(33); Osendarp et al.(34)).
Overall, the results of the present pilot study provide evi-
dence of modulation of CBF parameters in healthy young
adults following dietary supplementation with DHA-rich FO,
and at a dose (1 g/d) that would be achievable by dietary
intake of oily fish alone. Previously, studies that have aimed
to evaluate the effect of n-3 PUFA supplementation on beha-
vioural outcomes in healthy individuals have provided
mixed results. However, the data from the present study
suggest that an n-3 PUFA dietary supplement may indeed
have an impact on cerebrovascular function. Given these
interesting findings, further studies using NIRS and other
imaging techniques to assess the causal relationship between
n-3 PUFA intake and brain function are warranted.
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